Edit |   |
---|---|
Product Name | Imatinib mesylate |
Description | Imatinib mesylate is a small molecule which can act as a BCR-ABL inhibitor. It is provided as a powder. This product acts on the following target types: Kinase, Cytochrome. This product may be of interest in the following research areas and diseases: Cancer. This product may act as a Coronavirus inhibitor: Inhibits SARS-CoV and MERS-CoV in cells. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 493.62 g/mol 96.11 g/mol |
Size | 20 mg, 100 mg |
Concentration | n/a |
Applications | n/a |
Other Names | Imatinib mesylate, 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate, Gleevec, STI571, 220127-57-1 |
Gene, Accession, CAS # | CAS: 220127-57-1 |
Catalog # | abx076675 |
Price | please inquire |
Order / More Info | Imatinib mesylate from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950